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ABSTRACT  
Background/Objectives: Walking pace is thought to be associated with risk of premature 
mortality. However, the independence of this relationship from total volume of physical 
activity, non-occupationalleisure time physical activity and highest physical activity intensity 
reached remain unclear. We examined the associations between walking pace and cause-
specific mortality, investigating the potential modifying effect of these factors, as well as age, 
sex and BMI.   
Methods: Prospective pooled analysis of 11 population-based baseline surveys in England 
and Scotland between 1994-2008 that were linked with mortality records. Multivariate-
adjusted Cox proportional hazards models examined associations between walking pace 
(slow, average, brisk/fast) and all-cause, cancer, and CVD mortality.   
Results:  50,022 walkers were entered in the analyses. Compared to self-reported walking at 
a slow pace, walking at average or brisk/fast pace was associated with a reduced risk of all-
cause mortality (20% (95%CI=11-27%) and 23% (95%CI=12-32% respectively), and CVD 
mortality (23% (95%CI=8-35%) and 19% (95%CI=-2-36% respectively). In stratified 
analyses, such associations were evident amongst those over 50 years, those not meeting the 
physical activity recommendations, and those who did not undertake vigorous intensity 
activity. There was no interaction effect of sex or BMI. No association was seen between 
pace and cancer mortality. 
Conclusion: Walking is known to benefit health. Assuming causality, these analyses suggest 
that increasing walking pace could reduce risk for all-cause and CVD mortality. Walking 
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pace could be emphasised in public health messages, especially in situations when increase in 
walking volume or frequency is less feasible. 
Keywords 
Walking, physical activity, mortality, walking pace, epidemiology, public health, 
cardiometabolic, cohort studies  
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INTRODUCTION 
Increasing population level walking remains a key focus of physical activity (PA) promotion. 
Regular walking is known to confer many physical, mental and social health benefits.1 Meta-
analyses of cohort studies have sought to quantify the association between regular walking 
and reduction in risk for all-cause mortality (ACM).2-4 Kelly et al., (2014) estimated that after 
adjustment for other PA, walking at a volume equivalent to PA guidelines was associated 
with an 11% reduction in risk for ACM compared to no walking.5  
 
Considering other health endpoints,  cardiovascular disease (CVD)  and cancer are the two 
most common avoidable causes of mortality in the UK.6  Considering other health endpoints, 
Hamer and Chida (2008) conducted a meta-analysis of 13 cohort studies and found a 31% 
reduction in risk of CVD cardiovascular disease (CVD) mortality in the highest walking 
categories compared with the lowest walking volume/intensity category.2 A recent, large 
analysis of over 250,000 adults in the UK found walking commuting was associated with a 
36% reduction in risk of CVD mortality compared to non-active commuting.7 The results for 
cancer mortality are less clear, with, for example, Matthews et al., (2007) and Celis-Morales 
(2017) finding no significant associations between walking volume and cancer mortality in 
large cohort studies.7 8  
 
According to principles of overload a higher relative activity intensity achieved by a faster 
pace of walking would provide the stimulus to produce a greater physiological response, and 
more substantial or even additional health benefits. Acute studies have shown that walking at 
a faster pace results in greater physiological responses1. However, while total volume of 
walking e.g. by distance or time has been frequently studied2-5, less is known about the long-
term health effects of habitual walking pace. 
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A Copenhagen City Heart Study analysis9 reported reduced risk of heart failure for moderate 
and high walking speed compared to slow speed. The authors also suggested that walking 
pace may have a stronger association with heart failure than total duration of walking. Man-
son et al.,10  found that among 73,743 postmenopausal women aged 50-79 years walking pace 
was associated with reduced incidence of cardiovascular disease (CVD) in a dose-response 
fashion. In a 40-year follow up of the Whitehall study of 6,981 British civil servants, Batty et 
al.,11 compared slow walking pace to high walking pace and found a reduced risk of all-
cause, coronary heart disease (CHD), and total cancer mortality. None of these studies ad-
justed for total volume of PA and it is therefore unclear if the reported effects were partly at-
tributable to the higher overall activity levels of brisk/fast walkers.   
A recent analysis of 420,000 UK Biobank Participants found significant associations between 
higher walking pace and reduced risk of all-cause and cardiovascular mortality, but incon-
sistent findings for cancer mortality12.  However, the UK Biobank had a response rate of 
5.5% and concerns have been raised about the generalisability of non-genetic associations 
from very unrepresentative cohorts13.  
 
In summary, walking pace has been found to be associated with reduced risk of all-cause and 
cause-specific mortality in a number of cohort studies but the literature on the whole has not 
addressed independence from total and non-occupationalleisure time PA robustly. There remains a knowledge 
gap about the independence of the relationships between walking pace and mortality out-
comes in large population cohorts.  
 
Our aim was to examine the associations between self-reported walking pace with all-cause, 
CVD and cancer mortality in a population representative sample of 11 pooled population 
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British cohorts. A secondary aim was to better understand the role of total and total non-occupational leisure-
timeand PA, sex, age, and BMI as potential moderators of these associations.    
 
METHODS 
Sample 
The Health Survey for England (HSE)14  and the Scottish Health Survey (SHeS) 15 are estab-
lished household-based population surveillance studies running since 1991 and 1995, respec-
tively. Each year samples are selected using a multistage, stratified probability design aimed 
at recruiting a nationally representative sample of adults living in private households. Trained 
interviewers visited the selected households, and the recruited participants were administered 
the study questionnaires. 91.6% of survey participants gave written consent to have their 
death flagged on the NHS Central Mortality Register. For this analysis we used data from 
HSE 1994, 1997, 1998, 1999, 2003, 2004, 2006 and 2008 and SHeS 1995, 1998 and 2003.  
As population mortality rates increase  evidently from the 4th decade of life, Wwe included 
individuals aged ≥30 years old who reported at least one occasion of walking in the last four 
weeks, had no doctor-diagnosed or self-reported (long standing illness module) ischemic 
heart disease, angina, or stroke, and no prevalent cancer through cancer registration records 
or self-reported (long standing illness module). We chose 30 years as the lowest age for in-
clusion in the study because mortality events  An occasion of walking was variously defined 
as at least 10 minutes or at least 15 minutes or at least 30 minutes in the different baseline 
surveys16. Each baseline survey was approved by the relevant Research Ethics Committees in 
England and Scotland.   
 
Mortality outcomes 
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Participants were followed up for mortality until 31/12/2009 (SHeS) or 31/03/2011 (HSE).  
Diagnoses for primary causes of death were recorded according to the International Classifi-
cation of Diseases, Ninth Revision (ICD9) and Tenth Revision (ICD10). Cancer deaths were 
identified using ICD9 140.0-239.9 and ICD10 C00.0-D48.9 codes; CVD deaths were identi-
fied using ICD9 390.0-459.9 and ICD10 I01.0-I99 codes. 
 
Assessment of walking and other physical activity 
PA was assessed using a researcherinterviewer-led administered questionnaire that inquired 
about walking, domestic PA, and participation in sports and exercises in the four weeks prior 
to the interview16.  Walking was assessed using a question on number of days walked in the 
last 4 weeks, the average amount of time spent walking on each day, and the usual walking 
pace (“which of the following describes your usual walking pace: slow pace, average pace, 
fairly brisk pace, fast pace-at least 4mph”).  Because some baseline surveys (HSE 
1994/1999/2003/2004; SHeS 1995) did not enquire about walking duration per reported occa-
sion we imputed this information based on the age and sex-specific averages of HSE 
1997/1998 and using  methods described elsewhere17. All PA variables were summarized to 
reflect weekly averages for easier comparison with currently recommended amounts. The cri-
terion validity of the walking-related questions is unknown. In a convergent validity study of 
over 2000 adults, the Spearman correlation coefficients between accelerometry counts and 
walking of brisk/fast pace were 0.35 (95% confidence interval (CI): 0.31, 0.40) for women 
and 0.28 (CI: 0.23, 0.34) for men18.  The equivalent coefficients for total weekly question-
naire derived MET-minutes were 0.41 (CI: 0.36, 0.46) for women and 0.32 (CI: 0.26, 0.38) 
for men18.    
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The PA compendium19 was used to assign the Metabolic Equivalents (MET) for all PAs to 
calculate total MET-hours/week. We estimated adherence to the general guideline20  as accu-
mulating weekly at least 150 minutes of moderate intensity or 75 minutes of vigorous 
intensity or equivalent combinations of moderate and vigorous (non-occupationalleisure 
time) PA20.  We also calculated highest physical activty intensity reached on at least one 
occasion over the in the last four weeks that the PA questionaire time frame covered 
(light/moderate/vigorous).  
 
Covariates 
Height and weight were measured by the interviewers using standard protocols14 15; body 
mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) 
squared.  Additional questions assessed age, educational attainment (age completed full time 
education), presence of longstanding illness, weekly frequency of alcohol consumption, 
smoking habits (never smoker, ex-smoker, currently smoking 1-9 cigarettes/day, currently 
smoking 10-19/day, currently smoking ≥20/day), psychological distress/depression (12-point 
General Health Questionnaire score),  total leisure time PA volume (MET-hours/week) and 
total walking volume (MET-hours/week).   
 
Statistical analysis  
Analyses were conducted using SPSS version 22 (SPSS, Inc). Cox proportional-hazard mod-
els with time in study as the time-scale were used to examine the associations between walk-
ing pace and all-cause, CVD, and cancer mortality with “slow pace” as the reference cate-
gory. Walking pace was originally entered in its original 4 categories format but the low 
number of events in the “fast pace” category resulted in unstable estimates and broad 95% 
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CIs; for this reason, all main analyses were carried out with “fairly brisk” and “fast” pace cat-
egories collapsed into one group. In a supplemental analysis we entered walking pace in its 
original format.      
 
Kaplan Meier log-minus-log plots were used to examine the proportional-hazards assumption 
and no violations were observed.  Analyses were adjusted for age, sex, all covariates listed 
above, total volume of non-occupational leisure time PA (weekly MET-hours), and highest 
PA intensity reached. Occupational PA could not be used in the calculation of PA volume be-
cause of its non-quantitative nature (it is was reported as very/fairly/not very/not at all physi-
cally active). We chose not to adjust for occupational PA level in the main Cox models be-
cause of the large number of missing values (n≈27,000) due to the corresponding question 
missing from SHeS 1995 and for responses being dependant on employment status.  For 
these reasons we conducted a sensitivity analysis in the sub-sample who had valid occupational activity information (n=30,089).    
 
We examined effect modification by gendersex, age, and total non-occupational leisure time 
PA level using Type 3 Wald chi-square statistics for the interaction term in the partially ad-
justed (for age, sex, and cohort/year) model. For interactions with p<0.010 we performed 
stratified analyses20.  To minimize the possibility of spurious associations due to occult dis-
ease we ran a sensitivity analysis where we both included and excluded participants who died 
in the first 24 months of follow-up.   
 
RESULTS  
In total, 65,381 participants were initially considered; 4,811 participants (8.4% of total 
eligible) did not consent to follow up and were excluded. The variables with the highest 
number of missing data were BMI (n=6,346), GHQ score (n=2,444) and smoking (n=151). In 
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total, there were 3617 deaths from any cause including 1014 from CVD and 1276 from 
cancer causes. The mean follow up was 9.2 (SD=4.6) years, corresponding to 469,235 person 
years. Table 1 presents the sample characteristics for the 50,225 individuals in the analytical 
sample. Slower walking pace was associated with older age, female sex, higher BMI scores, 
reporting a long-standing illness at baseline, and indications of psychological distress. Faster 
walking pace was associated with being a smoker, high frequency of alcohol consumption, 
finishing education after age 19 years, meeting the PA recommendations, participating in 
higher intensity PA, high volumes of total non-occupational leisure time PA, and higher 
frequency and total duration of walking. Walking pace (in its original 4-group format) 
showed low magnitude correlations with total leisure time PA volume (Spearman rho=0.25) 
and walking volume (rho=0.20). 
 
Table 2 presents the associations between walking pace and the three mortality outcomes 
with all participants who had an event in the first 24 months of the follow-up excluded 
(n=49,731). In the fully adjusted models, walking at an average pace was associated with a 
risk reduction for ACM of 20% (95%CI:1112-2728%) compared with those walking at a 
slow pace. The respective risk reduction for those walking at brisk/fast pace was 2324% 
(1213-3233%). For CVD mortality, walking at an average pace was associated with a 2324% 
(89-3536%) risk reduction and walking at a brisk/fast pace was associated with 1921% (21-
3638%) risk reduction compared with those walking at a slow pace. There was no evidence to 
suggest walking at an average or brisk/fast pace was associated with a significant risk 
reduction in cancer mortality (hazard ratio (HR)=1.08 (0.9089-1.31) and HR=1.03 02 
(0.8281-1.29) respectively). The results were similar in direction and magnitude when those 
who had an event in the first 24 months were included (Supplemental Table 1). When the 
walking pace variable was entered in its original 4-group format (Supplemental Table 2) 
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associations were similar in magnitude and direction but likely due to lower number of 
events, the 95% CI of the fast pace group were very wide and included 1 for all three 
outcomes. Repeating all above analyses with the models adjusted for total duration of MVPA 
and light intensity activity (instead of average MET-hours per week) produced almost 
identical results, for example the HR(95%CI) for all-cause mortality in the average pace 
group changed from 0.80 (0.72 to 0.88) to 0.80 (0.73 to 0.88);  in the brisk/fast group it 
changed from 0.76 (0.67, 0.87) to 0.77 (0.68, 0.88)  (data available on request).  
 
There were statistically significant interaction effects of walking pace and total non-
occupational leisure time PA volume (e.g. p=0.038 for ACM) and highest intensity reached 
(e.g. p=0.004 for ACM). Significant interaction effects were also found for walking pace and 
age (e.g. p=0.005 for ACM) but not for sex or BMI.  
 
Stratified analyses by age in two and three groups are presented in Figure 1 and 
Supplemental Figure 1 respectively, and by compliance with the PA recommendations in 
Figure 2. Figure 1 shows clearer evidence of a relationship between walking pace and all-
cause and CVD mortality, but not cancer mortality, in the over 50s compared to the results 
for the whole sample. There was little evidence of association in the under 50s. 
Supplemental Figure 1 showed clearer evidence for a relationship of walking pace with all-
cause mortality in those aged 45-59 and ≥60 years and with CVD mortality in those aged ≥60 
years.  
 
Figure 2 shows clearer evidence of a relationship between walking pace and all-cause and 
CVD mortality, but not cancer mortality, amongst those that did not meet the PA guidelines    
compared to the results of the whole sample. For those meeting the guidelines, the direction 
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of effect for all cause and CVD mortality was protective for increasing pace, but very low 
number of events caused low power and wide confidence intervals.  
 
Figure 3 shows the stratified analyses of walking pace and all-cause and CVD mortality by 
highest intensity reached; analyses were not performed for cancer mortality due to the low 
number of events in some cells and the apparent violation of the proportional hazards 
assumption. There was evidence of a relationship between walking pace and ACM in both 
the light and moderate intensity groups. There was some evidence for a relationship with 
CVD mortality in these groups although confidence intervals were wider and there was no 
dose-response. There was no evidence of a relationship between walking pace and all-cause 
or CVD mortality amongst the group that reported reaching vigorous intensity.  
 
DISCUSSION  
In adults in Scotland and England, walking at average or brisk/fast pace was associated with a 
reduced risk of all-cause and CVD mortality compared with walking at slow pace. However, 
there was no evidence of a similar relationship with cancer mortality. Our findings are in 
agreement with previous studies which have reported that a higher pace of walking was 
associated with a risk reduction for ACM of between 19%21 and 42%11. Our estimates are 
within this range, and adjusted for total PA volume (MET-hrs/week), considered 
occupational PA, and highest PA intensity reached. We found that the associations between 
pace and all-cause mortality persisted after controlling for total non-occupation PA which is 
consistent with studies that controlled for total walking energy expenditure22 and moderate 
and vigorous PA12.  Batty et al., reported a 20% reduction in cancer mortality for walking 
fast.11 Similar to Yates et al., (2017)12 we did not find any evidence of this effect.   
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Possible explanations 
The association between pace on all-cause and CVD mortality may be explained by the 
increased relative exercise intensity elicited by a faster pace providing a greater stimulus for 
physiologic adaptations23 in functions known to influence CVD mortality. This may be 
further confirmed by the observation that the associations of walking pace with ACM and 
CVD mortality were considerably weakened for the subsample of participants that have 
achieved vigorous intensity in non-walking physical activity.  
 
We did not find an effect of pace on cancer mortality. Volume may be more important than 
pace for cancer mortality. Alternatively we know that different cancers have different 
relationships with PA, and that if we had examined mortality from specific malignancies e.g., 
breast and colon cancer a relationship may have been observed24.  
 
We did not find evidence for associations for the younger participants, the physically active, 
or for those reaching vigorous intensity, but recommend caution when interpreting these 
findings. Low number of events in strata increased uncertainty. It is possible that older age 
and lower PA status (total or intensity) predict lower aerobic fitness (maximal oxygen 
consumption). As such, that the relative intensity of walking at faster pace may be equivalent 
to the upper end of moderate intensity or even vigorous intensity, and therefore provides a 
greater physiological stimulus for maintaining cardiovascular function and promoting health.  
 
Separating the effect of one specific aspect of physical activity and understanding, its 
potentially causal association with mortality is complex.  Our data suggest that participants 
who usually walk at a brisk/fast pace are overall the most active and probably the  healthiest. 
Finally,Although it is biologically plausible that walking at a higher pace leads to better 
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health overall and cardiovascular health specifically, it is also likely that walking at a faster 
pace is a marker for better health and, fitness, and physical function, which predicts the risk for 
mortality in the following years. In other words, walking pace may be a predictor and not a 
causal factor of lower mortality risk.  
 
Strengths and limitations 
The strengths of the present study include the large sample comprising a series of baseline 
surveys that were roughly representative of the population in England and Scotland, the very 
high response rates, and the relatively long follow up. The results can be generalised to the 
UK population with more confidence than previous estimates. To our knowledge this is the 
first such study to report associations between walking pace and all-cause, CVD, and cancer 
mortality and adjust for total PA volume and highest intensity reached. We also present novel 
analysis of associations stratified by age, total non-occupational leisure time PA and highest 
intensity reached to investigate important potential effect modifiers.  
 
Limitations include:  the exposure “walking pace” and other variables such as “total PA” 
were self-reported and therefore subject to misclassification and other biases. Further 
misclassification may have been introduced by the imputation of walking duration for a 
number of baseline surveys17, and this may be partly the reason why adjustments for total 
walking volume  had negligible impact on the estimates.  The repeated- cross-sectional nature 
of HSE and SHeS the survey data meant we could not assess or account for temporal changes 
in walking behavior within individuals. The analyses controlled for a comprehensive set of 
covariates in addition to PA, although we cannot discount the possibility of residual 
confounding. Some stratified analyses had too few events and therefore may not have been 
powerful enough to detect associations or lack  of association with confidence.    
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Implications and future research 
The additional protective effect demonstrated from higher walking pace may have implications 
for public health messaging.  Walking is a cornerstone of PA promotion for public health, but 
volume of walking (steps per day) has often been emphasised.  Given the perceived time barrier 
cited by those who fail to meet current PA guidelines25, a pace change could be more feasible 
(for those with adequate physical capacity) than increased volume or duration. We encourage 
the Chief Medical Officers’ Physical Activity Guidelines Committee to consider this in their 
upcoming revision of the PA Guidelines. Further experimental research is warranted to 
establish if a randomised intervention based on pace elicits important physiological change26.   
 
Conclusions 
Walking is known to benefit health. Assuming causal relationships, these analyses suggest 
that increasing walking pace could be linked with lower risk for all-cause and CVD mortality. 
Walking pace should be emphasised in public health messages, especially in circumstances 
when increase in walking volume or frequency is less feasible. 
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FIGURE LEGENDS  
 
Figure 1: Associations between walking pace (3 groups)  and all-cause, cardiovascular dis-
ease, and cancer mortality by age group (<50 vs. ≥50 years) a.  Walkers aged 30 years and 
over with no diagnosed cardiovascular disease or cancer at baseline b.  The Health Survey for 
England and Scottish Health Survey (n=50,225).   
 
 
50 years of age was selected as a cutoff point due to its proximity to median age for this sample (48 
years)  b Prevalent cardiovascular disease was defined as doctor-diagnosed or self-reported (long 
standing illness module) ischemic heart disease, angina, or stroke; prevalent cancer was determined 
through cancer registration records or self-reported (long standing illness module) cModel adjusted for  
sex,   cohort,   long-standing illness, alcohol drinking frequency, psychological distress, body mass 
index, smoking status, education level,  total physical activity volume (MET-hrs/week), walking vol-
ume (MET-hrs/week), and  highest physical activity intensity reached. 
 
 
Figure 2: Associations between walking pace (3 groups)  and all-cause, cardiovascular dis-
ease, and cancer mortality,  by physical activity level (meeting  vs. not meeting the physical 
activity recommendations).a Walkers aged 30 years and over with no diagnosed cardiovascu-
lar disease or cancer at baseline b.  The Health Survey for England and Scottish Health Survey  
(n=50,225).   
 
a Adherence to the physical activity recommendations was defined as at least 150 minutes of moder-
ate-intensity activity or 75 minutes per week of vigorous intensity activity or equivalent combinatins 
of moderate and vigorous activity b Prevalent cardiovascular disease was defined as doctor-diagnosed 
or self-reported (long standing illness module) ischemic heart disease, angina, or stroke; prevalent 
cancer was determined through cancer registration records or self-reported (long standing illness mod-
ule) cModel adjusted for  sex,   cohort,   long-standing illness, alcohol drinking frequency, psychologi-
cal distress, body mass index, smoking status, education level, walking volume (MET-hrs/week),   
highest physical activity intensity reached. 
 
 
Figure 3: Associations between walking pace (3 groups)  and all-cause, and cardiovascular 
disease mortality, by highest physical activity intensity reached (light/moderate/vigorous). 
Walkers aged 30 years and over with no diagnosed cardiovascular disease or cancer at base-
line a.  The Health Survey for England and Scottish Health Survey  (n=50,225).   
 
a Prevalent cardiovascular disease was defined as doctor-diagnosed or self-reported (long standing ill-
ness module) ischemic heart disease, angina, or stroke; prevalent cancer was determined through can-
cer registration records or self-reported (long standing illness module) bModel adjusted for  sex,   co-
hort,   long-standing illness, alcohol drinking frequency, psychological distress, body mass index, 
smoking status, education level,  walking volume (MET-hrs/week), and  total physical activity vol-
ume (MET-hrs/week).  
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  Table 1.  Baseline characteristics of the sample by walking pace. Walkers aged 30 years and over with no diagnosed cardiovascular 
disease or cancer at baseline.  The Health Survey for England and Scottish Health Survey (n=50,225).   
 Walking Pace  
 Slow Pace Average Pace Fairly Brisk 
Pace 
Fast Pace   
     Pe    
Age, mean (SD) (years) 57.8 51.1 47.7 44.6 <0.001 
Sex (% female) 61.0 58.5 52.2 40.5 <0.001 
Body mass index, mean (SD) (kg/m2)  28.6 (5.7) 27.3 (4.7) 26.1 (4.1) 25.5 (3.9) <0.001 
Long standing illness a (%) 64.6 41.9 35.4 33.0 <0.001 
Smoking (% current) 23.9 24.0 21.5 27.5 <0.001 
Alcohol frequency (% ≥5 times/week)b 18.7 18.7 22.4 24.5 <0.001 
Psychological distress  (% with GHQ 
score ≥4)c 
20.1 11.9 11.6 12.2 <0.001 
Age finished education (% finished age 
19+) 
12.9 18.1 26.3 29.0 <0.001 
Meeting the physical activity recommen-
dations d  
8.9 17.2 47.5 52.4 <0.001 
Highest PA intensity reached (%) 
No physical activity  
Light intensity  only 
Reached moderate inensity  
Reached vigorous intensity 
 
11.7 
63.4 
11.8 
13.1 
 
7.9 
52.5 
15.3 
24.3 
 
4.9 
14.4 
42.9 
37.7 
 
4.9 
14.8 
37.2 
43.0 
 
<0.001 
MET-hours of physical activity per week, 
median (SE) 
8.0 (0.38) 17.0 (0.20) 23.1 (0.31) 32.0 (0.80) <0.001 
Number of days walked per week, median 
(SE) 
2.0 (0.04) 2.5 (0.02) 2.5 (0.02) 3.0 (0.05) <0.001 
Time (minutes) walked per week (any 
pace), median (SE) 
67.5 (5.24) 112.5 (2.44) 110.0 (3.10) 130.0 (8.67) <0.001 
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aDichotomous variable derived from responses to a series of questions (yes/no) on illness within 8 listed body systems (eg. nervous system, digestive sys-
tem, heart and circulatory system etc.). At least one illness required to have longstanding illness;b derived from the question “on how many days in the last 
7 days did you have an alcoholic drink; c General Health Questionnaire comprises 12 questions related to psychological health (eg. concentration, feeling 
depressed etc) the categories were 0, 1-3 and ≥4;  d at least 150 minutes of moderate-intensity activity or 75 minutes per week of vigorous intensity activity 
or equivalent combinatins of moderate and vigorous activity;); e P-value calculated using Kruskal-Wallis test for continuous variables and likelihood ratio 
chi-square test for categorical variables.  
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Table 2:   Associations between walking pace (3 groups)  and all-cause, cardiovascular disease, and cancer mortality.  Walkers aged 
30 years and over with no diagnosed cardiovascular disease or cancer at baselinea excluding deaths occuringoccurring the first 24 
months of follow up.  The Health Survey for England and Scottish Health Survey (n=49,731).   
 
Deaths/n 
Model 1b Model 2c Model 3d 
HR 95% CIs HR 95% CIs HR 95% CIs 
All-cause Mortality        
Walking Pace          
Slow  576/4101 1  1  1  
Average 1957/25857 0.73 0.67,0.81 0.78 0.71,0.87 0.80 0.7372,0.8988 
Brisk/Fast 730/19773 0.61 0.55,0.69 0.68 0.61,0.77 0.7776 0.6867,0.8887 
P trend linear  <0.001  <0.001  <0.001  
P trend nonlinear  <0.001  0.003  0.001  
        
Cardiovascular Mor-
tality 
       
Walking Pace          
Slow  192/4101 1  1  1  
Average 552/25857 0.68 0.57,0.81 0.75 0.63,0.90 0.7776 0.6564,0.9291 
Brisk/Fast 
193/19773 0.55 0.45,0.68 0.67 0.54,0.83 0.8179 
0.6462,1 
0.0299 
P trend linear  <0.001  0.001  0.143089  
P trend nonlinear  0.007  0.032  0.008007  
        
Cancer Mortality        
Walking Pace          
Slow  137/4101 1  1  1  
Average 717/25857 1.03 0.85,1.24 1.06 0.88,1.29 1.08 0.9089,1.31 
Brisk/Fast 297/19773 0.88 0.71,1.08 0.95 1.95,0.76, 1.17 1.0302 0.8281,1.29 
P trend linear  0.152  0.478  0.930945  
P trend nonlinear  0.338  0.269  0.327339  
a Prevalent cardiovascular disease was defined as doctor-diagnosed or self-reported (long standing illness module) ischemic heart disease, angina, or stroke; 
prevalent cancer was determined through cancer registration records or self-reported (long standing illness module) bModel adjusted for age,    sex, and 
cohort;   cModel also adjusted for  long-standing illness, alcohol drinking frequency, psychological distress, body mass index, smoking status, education 
Formatted: Font color: Auto
BJSM Special Issue, Walking to Health 2018  
 
20 
 
 
level;   dModel also adjusted for total physical activity volume (MET-hrs/week),  walking volume (MET-hrs/week),  and  highest physical activity intensity 
reached. 
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